Biosimilar Drugs Market Future Trends in United States
نویسندگان
چکیده
منابع مشابه
The Cost Savings Potential of Biosimilar Drugs in the United States
T he U.S. Food and Drug Administration (FDA) is expected to release final regulations outlining lower-cost approval pathway requirements for so-called biosimilar drugs. The introduction of biosimilars is expected to reduce prices, albeit
متن کاملTrends in the United States
were living with HIV/AIDS and that 21.8 million people had died with HIV disease by the end of 2000. In 2000, there were an estimated 5.3 million new HIV infections and 3 million AIDS deaths. The most important events in the second decade of the epidemic have been the introduction of new antiretroviral regimens, the advent of effective interventions to prevent mother-to-child transmission of HI...
متن کاملTrends in the United States
As developers of a psychotherapy for depression, we bring a point of view to the topic of the future of antidepressant psychotherapies. Let us state this view up front and emphasize it reflects that most of our experience has been in the United States. Our guiding principles are: • Psychotherapies, like any treatments, should be evidenced based. Evidence is best derived from randomized controll...
متن کاملHealth System Reform in the United States
In 2010, the United States adopted its first-ever comprehensive set of health system reforms in the Affordable Care Act (ACA). Implementation of the law, though politically contentious and controversial, has now reached a stage where reversal of most elements of the law is no longer feasible. The controversial portions of the law that expand affordable health insurance coverage to most U.S. cit...
متن کاملTuberculosis Trends — United States, 2014
In 2014, a total of 9,412 new tuberculosis (TB) cases were reported in the United States, with an incidence rate of 3.0* cases per 100,000 persons, a decrease of 2.2% from 2013. Although overall numbers of TB cases and rates continue to decline, the percentage decrease in rate is the smallest decrease in over a decade (1). This report summarizes provisional TB surveillance data reported to CDC'...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pharmaceutica Analytica Acta
سال: 2017
ISSN: 2153-2435
DOI: 10.4172/2153-2435.1000543